Cargando…

Genetic Variants in Hormone-Related Genes and Risk of Breast Cancer

Sex hormones play a key role in the development of breast cancer. Certain polymorphic variants (SNPs and repeat polymorphisms) in hormone-related genes are associated with sex hormone levels. However, the relationship observed between these genetic variants and breast cancer risk has been inconsiste...

Descripción completa

Detalles Bibliográficos
Autores principales:	Clendenen, Tess, Zeleniuch-Jacquotte, Anne, Wirgin, Isaac, Koenig, Karen L., Afanasyeva, Yelena, Lundin, Eva, Arslan, Alan A., Axelsson, Tomas, Försti, Asta, Hallmans, Göran, Hemminki, Kari, Lenner, Per, Roy, Nirmal, Shore, Roy E., Chen, Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3720532/ https://www.ncbi.nlm.nih.gov/pubmed/23935996 http://dx.doi.org/10.1371/journal.pone.0069367

Ejemplares similares

Genetic Polymorphisms in Vitamin D Metabolism and Signaling Genes and Risk of Breast Cancer: A Nested Case-Control Study
por: Clendenen, Tess V., et al.
Publicado: (2015)

Circulating levels of 25-hydroxyvitamin D and risk of breast cancer: a nested case-control study
por: Scarmo, Stephanie, et al.
Publicado: (2013)

Genotyping of Single Nucleotide Polymorphisms in DNA Isolated from Serum Using Sequenom MassARRAY Technology
por: Clendenen, Tess V., et al.
Publicado: (2015)

Circulating Vitamin D and Risk of Epithelial Ovarian Cancer
por: Arslan, Alan A., et al.
Publicado: (2009)

Circulating soluble Fas levels and risk of ovarian cancer
por: Akhmedkhanov, Arslan, et al.
Publicado: (2003)

Temporal reliability of cytokines and growth factors in EDTA plasma
por: Clendenen, Tess V, et al.
Publicado: (2010)

Premenopausal serum androgens and breast cancer risk: a nested case-control study
por: Zeleniuch-Jacquotte, Anne, et al.
Publicado: (2012)

Postmenopausal circulating levels of 2- and 16α-hydroxyestrone and risk of endometrial cancer
por: Zeleniuch-Jacquotte, A, et al.
Publicado: (2011)

Long-Term Exposure to Walkable Residential Neighborhoods and Risk of Obesity-Related Cancer in the New York University Women’s Health Study (NYUWHS)
por: India-Aldana, Sandra, et al.
Publicado: (2023)

Temporal reproducibility of IgG and IgM autoantibodies in serum from healthy women
por: Clendenen, T. V., et al.
Publicado: (2022)

Breast cancer risk prediction in women aged 35–50 years: impact of including sex hormone concentrations in the Gail model
por: Clendenen, Tess V., et al.
Publicado: (2019)

Defining the genomic signature of the parous breast
por: Peri, Suraj, et al.
Publicado: (2012)

Serum Taurine and Stroke Risk in Women: A Prospective, Nested Case-Control Study
por: Wu, Fen, et al.
Publicado: (2016)

Genomic signature of parity in the breast of premenopausal women
por: Santucci-Pereira, Julia, et al.
Publicado: (2019)

Postmenopausal levels of oestrogen, androgen, and SHBG and breast cancer: long-term results of a prospective study
por: Zeleniuch-Jacquotte, A, et al.
Publicado: (2004)

Incidence, Mortality and Survival Trends in Breast Cancers Coincident with Introduction of Mammography in the Nordic Countries
por: Hemminki, Kari, et al.
Publicado: (2022)

Survival in colon and rectal cancers in Finland and Sweden through 50 years
por: Hemminki, Kari, et al.
Publicado: (2021)

Circulating enterolactone and risk of breast cancer: a prospective study in New York
por: Zeleniuch-Jacquotte, A, et al.
Publicado: (2004)

Reliability of follicle-stimulating hormone measurements in serum
por: Arslan, Alan A, et al.
Publicado: (2003)

Aspirin and lung cancer in women
por: Akhmedkhanov, A, et al.
Publicado: (2002)

Incidence, mortality and survival in malignant pleural mesothelioma before and after asbestos in Denmark, Finland, Norway and Sweden
por: Hemminki, Kari, et al.
Publicado: (2021)

Cervical, vaginal and vulvar cancer incidence and survival trends in Denmark, Finland, Norway and Sweden with implications to treatment
por: Hemminki, Kari, et al.
Publicado: (2022)

Incidence and survival in laryngeal and lung cancers in Finland and Sweden through a half century
por: Koskinen, Anni, et al.
Publicado: (2022)

Survival trends in hematological malignancies in the Nordic countries through 50 years
por: Hemminki, Kari, et al.
Publicado: (2022)

Survival in hematological malignancies in the Nordic countries through a half century with correlation to treatment
por: Hemminki, Kari, et al.
Publicado: (2023)

Conditional survival in breast cancer up to 10 years in the Nordic countries
por: Zitricky, Frantisek, et al.
Publicado: (2023)

Early pregnancy sex steroids during primiparous pregnancies and maternal breast cancer: a nested case–control study in the Northern Sweden Maternity Cohort
por: Fortner, Renée T., et al.
Publicado: (2017)

Systematic enrichment analysis of gene expression profiling studies identifies consensus pathways implicated in colorectal cancer development
por: Lascorz, Jesús, et al.
Publicado: (2011)

Incidence, mortality and survival in multiple myeloma compared to other hematopoietic neoplasms in Sweden up to year 2016
por: Hemminki, Kari, et al.
Publicado: (2021)

Progress in survival in renal cell carcinoma through 50 years evaluated in Finland and Sweden
por: Hemminki, Kari, et al.
Publicado: (2021)

Incidence trends in bladder and lung cancers between Denmark, Finland and Sweden may implicate oral tobacco (snuff/snus) as a possible risk factor
por: Hemminki, Kari, et al.
Publicado: (2021)

Survival in bladder and upper urinary tract cancers in Finland and Sweden through 50 years
por: Hemminki, Kari, et al.
Publicado: (2022)

Long-term survival trends for primary liver and pancreatic cancers in the Nordic countries
por: Hemminki, Kari, et al.
Publicado: (2022)

Survival in gastric and esophageal cancers in the Nordic countries through a half century
por: Hemminki, Kari, et al.
Publicado: (2023)

Survival in Lung Cancer in the Nordic Countries Through A Half Century
por: Tichanek, Filip, et al.
Publicado: (2023)

Survival in melanoma in the nordic countries into the era of targeted and immunological therapies
por: Tichanek, Filip, et al.
Publicado: (2023)

Survival in Kidney and Bladder Cancers in Four Nordic Countries through a Half Century
por: Tichanek, Filip, et al.
Publicado: (2023)

Conditional Survival in Prostate Cancer in the Nordic Countries Elucidates the Timing of Improvements
por: Zitricky, Frantisek, et al.
Publicado: (2023)

Long-Term Periodic and Conditional Survival Trends in Prostate, Testicular, and Penile Cancers in the Nordic Countries, Marking Timing of Improvements
por: Tichanek, Filip, et al.
Publicado: (2023)

Survival, Incidence, and Mortality Trends in Female Cancers in the Nordic Countries
por: Tichanek, Filip, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_acjjujvqq68c7ko2301bn2s34s